JPRN-UMIN000031053已完成未知
The efficacy test of KTT002 - The efficacy test of KTT002
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 345
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects with a history of allergy or might be liable to allergy related to the study 2) Subjects who have serious historical disease, marked impairment, or treatment in the liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism system 3) The pregnant and subjects who hope to get pregnant during the exam period 4) Subjects who are ineligible due to life-style questionnaire 5) Subjects deemed inappropriate to participate in this study by the principle investigator.
研究者
相似试验
未知
2 期
TK-FT Phase 2 Study (Efficacy and Safety Study)Breakthrough cancer painJPRN-jRCT2080220503TEIKOKU SEIYAKU CO., LTD.50
已完成
不适用
Efficacy test of II001 systemHealthy adultsJPRN-UMIN000034342Kao Corporation5
已完成
不适用
Efficacy test for evaluating the effect of "composition A" on the skin redness.Healthy peopleJPRN-UMIN000029583Kao Corporation25
已完成
2 期
A Phase II study to confirm the effectiveness of TS-1 plus docetaxel for aged patients with advanced and/or metastatic gastric cancer (OGSG 0902)advanced and/or metastatic gastric cancerJPRN-UMIN000002785Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)31
进行中（未招募）
1 期
Essai de phase II évaluant l’efficacité et la tolérance de bevacizumab associé à une chimiothérapie dans le traitement de patients atteints de tumeurs endocrines digestives bien différenciées, progressives, localement avancées/métastatiques - BETTERTumeurs endocrines digestives et duodéno-pancréatiquesMedDRA version: 8.1Level: PTClassification code 10007279Term: Carcinoid tumour of the gastrointestinal tractEUCTR2006-005144-84-FRRoche SAS81